Skip to Main Content

Author Details

Peter J Hulick
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
2000
65
28
PMIDPaper TitleJournal TitlePublished Year
36781323Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.Clin Lung Cancer2023
37560999Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.J Clin Endocrinol Metab2023
37334598Refining Risk for Alzheimer's Disease Among Heterozygous APOEɿ4 Carriers.J Alzheimers Dis2023
37419004Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.Thromb Res2023
36781323Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.Clin Lung Cancer2023
37560999Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.J Clin Endocrinol Metab2023
37419004Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.Thromb Res2023
37334598Refining Risk for Alzheimer's Disease Among Heterozygous APOEɿ4 Carriers.J Alzheimers Dis2023
33443076Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.J Med Genet2022
36353656Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.Eur Urol Open Sci2022
35887642Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System.J Pers Med2022
36275420Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk.Int J Cardiol Heart Vasc2022
33443076Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.J Med Genet2022
35347252Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.Prostate Cancer Prostatic Dis2022
35347252Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.Prostate Cancer Prostatic Dis2022
36275420Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk.Int J Cardiol Heart Vasc2022
36353656Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.Eur Urol Open Sci2022
35887642Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System.J Pers Med2022
33270363Flype: Software for enabling personalized medicine.Am J Med Genet C Semin Med Genet2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34254341Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.Prostate2021
34312282Implementing Primary Care Mediated Population Genetic Screening Within an Integrated Health System.J Am Board Fam Med2021
33596141Patient-Reported Outcomes and Experiences with Population Genetic Testing Offered Through a Primary Care Network.Genet Test Mol Biomarkers2021
33257031Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Eur Urol2021
33300603Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.Int J Cancer2021
33270363Flype: Software for enabling personalized medicine.Am J Med Genet C Semin Med Genet2021
34404389Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.BMC Med2021
34732190Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.BMC Med2021
34672204The integration of personalized medicine into health systems: progress and a path forward.Per Med2021
34945714The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System.J Pers Med2021
33596141Patient-Reported Outcomes and Experiences with Population Genetic Testing Offered Through a Primary Care Network.Genet Test Mol Biomarkers2021
34945714The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System.J Pers Med2021
34672204The integration of personalized medicine into health systems: progress and a path forward.Per Med2021
34732190Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.BMC Med2021
34404389Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.BMC Med2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34312282Implementing Primary Care Mediated Population Genetic Screening Within an Integrated Health System.J Am Board Fam Med2021
34254341Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.Prostate2021
33257031Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Eur Urol2021
33300603Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.Int J Cancer2021
32830201Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.Br J Cancer2020
32020508Primary care physician experiences utilizing a family health history tool with electronic health record-integrated clinical decision support: an implementation process assessment.J Community Genet2020
31723001Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness.Cancer Res2020
33066060Primary Care Physician Experiences with Integrated Population-Scale Genetic Testing: A Mixed-Methods Assessment.J Pers Med2020
32891193Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.Am J Hum Genet2020
33409458Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers.JNCI Cancer Spectr2020
32830201Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.Br J Cancer2020
31723001Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness.Cancer Res2020
32020508Primary care physician experiences utilizing a family health history tool with electronic health record-integrated clinical decision support: an implementation process assessment.J Community Genet2020
33066060Primary Care Physician Experiences with Integrated Population-Scale Genetic Testing: A Mixed-Methods Assessment.J Pers Med2020
  • 1 - 50 of 130

Recommended Authors

Massachusetts General Hospital
Career Start Year 2018
Number of shared co-authors 1
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2017
Number of shared co-authors 1
SD Sanford School of Medicine, University of South Dakota
Career Start Year 2016
Number of shared co-authors 3
VA Salt Lake City Healthcare System (VINCI)
Career Start Year 2013
Number of shared co-authors 8
Kaiser Permanente Center for Health Research
Career Start Year 2012
Number of shared co-authors 4
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 7
Nationwide Children's Hospital, The Ohio State University College of Medicine
Career Start Year 2010
Number of shared co-authors 4
King Edward Memorial Hospital
Career Start Year 2009
Number of shared co-authors 25
Harvard Medical School, Brigham and Women's Hospital
Career Start Year 2009
Number of shared co-authors 14
Vagelos College of Physicians and Surgeons, Columbia University
Career Start Year 2007
Number of shared co-authors 14
University of Maryland School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Genomic Medicine Institute, Geisinger Medical Center
Career Start Year 2005
Number of shared co-authors 14
Duke University School of Medicine
Career Start Year 2004
Number of shared co-authors 5
Invitae Corporation
Career Start Year 2004
Number of shared co-authors 8
Center for Applied Genomics and Precision Medicine, Duke University
Career Start Year 2003
Number of shared co-authors 4
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 12
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 5
Institute for Public Health Genetics, University of Washington
Career Start Year 2000
Number of shared co-authors 15
University of North Carolina
Career Start Year 1999
Number of shared co-authors 13
Duke University School of Medicine
Career Start Year 1999
Number of shared co-authors 2
Genomic Medicine Institute
Career Start Year 1994
Number of shared co-authors 9
Dartmouth Geisel School of Medicine
Career Start Year 1993
Number of shared co-authors 6
Center for Health Research, Kaiser Permanente Northwest
Career Start Year 1993
Number of shared co-authors 18
College of Medicine, The Ohio State University
Career Start Year 1992
Number of shared co-authors 33
Genomic Medicine Institute
Career Start Year 1991
Number of shared co-authors 8
University of North Carolina
Career Start Year 1989
Number of shared co-authors 13
University of Michigan School of Medicine ann arbor
Career Start Year 1989
Number of shared co-authors 2
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 21
University of Washington Medical Center
Career Start Year 1985
Number of shared co-authors 25
The Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 16

Collaborators

Mayo Clinic
Co-authored papers 21
QIMR Berghofer Medical Research Institute
Co-authored papers 20
University of Toronto
Co-authored papers 20
Ospedale Circolo e Fondazione Macchi
Co-authored papers 19
Instituto de Salud Carlos III
Co-authored papers 18
Invitae Corporation
Co-authored papers 18
University of Cambridge
Co-authored papers 18
Co-authored papers 18
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 18
University of Utah
Co-authored papers 17
Dana-Farber Cancer Institute
Co-authored papers 17
Co-authored papers 16
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 15
Co-authored papers 15
David Geffen School of Medicine, University of California los angeles
Co-authored papers 15
Co-authored papers 14
Pomeranian Medical University
Co-authored papers 14
QIMR Berghofer Medical Research Institute
Co-authored papers 13
Co-authored papers 13
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 13
The Institute of Cancer Research
Co-authored papers 12
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 12
Co-authored papers 12
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 12
German Cancer Research Center (DKFZ)
Co-authored papers 11
Co-authored papers 11
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 11
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 11
Otto-Friedrich-University Bamberg
Co-authored papers 10
University of California irvine
Co-authored papers 10